| Literature DB >> 21256756 |
Kevin K-C Liu1, Subas M Sakya, Christopher J O'Donnell, Andrew C Flick, Jin Li.
Abstract
New drugs are introduced to the market every year and each individual drug represents a privileged structure for its biological target. These new chemical entities (NCEs) provide insights into molecular recognition and also serve as leads for designing future new drugs. This review covers the syntheses of 21 NCEs marketed in 2009.Mesh：
Substances：
Year: 2010 PMID： 21256756 DOI： 10.1016/j.bmc.2010.12.038
Source DB: PubMed Journal: Bioorg Med Chem ISSN： 0968-0896 Impact factor: 3.641